Lara al-Titi, works on ingredients inside her workshop for camel milk soap production, in Irbid, Jordan June 14, 2021. Picture taken June 14, 2021. REUTERS/Alaa Al Sukhni

Vials containing Sputnik V vaccines against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia are seen at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli

An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli

An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli

An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli

Belgian yoga teacher Dorien Dierckx, 29 from Brussels serves herselve a beer while relaxing in a jacuzzi full of hot water and a mixture of ingredients used to make beer, and where customers can serve their own beer from the tap at the Good Beer Spa in Brussels, Belgium May 12, 2021. REUTERS/Yves Herman

Belgian yoga teacher Dorien Dierckx, 29 from Brussels enjoys a beer while relaxing in a jacuzzi full of hot water and a mixture of ingredients used to make beer, and where customers can serve their own beer from the tap at the Good Beer Spa in Brussels, Belgium May 12, 2021. REUTERS/Yves Herman

Belgian yoga teacher Dorien Dierckx, 29 from Brussels enjoys a beer while relaxing in a jacuzzi full of hot water and a mixture of ingredients used to make beer, and where customers can serve their own beer from the tap at the Good Beer Spa in Brussels, Belgium May 12, 2021. REUTERS/Yves Herman

Belgian yoga teacher Dorien Dierckx, 29 from Brussels drinks a beer while relaxing in a jacuzzi full of hot water and a mixture of ingredients used to make beer, and where customers can serve their own beer from the tap at the Good Beer Spa in Brussels, Belgium May 12, 2021. REUTERS/Yves Herman

Belgian yoga teacher Dorien Dierckx, 29 from Brussels enjoys a beer while relaxing in a jacuzzi full of hot water and a mixture of ingredients used to make beer, and where customers can serve their own beer from the tap at the Good Beer Spa in Brussels, Belgium May 12, 2021. REUTERS/Yves Herman TPX IMAGES OF THE DAY

Belgian yoga teacher Dorien Dierckx, 29 from Brussels enjoys a beer while relaxing in a jacuzzi full of hot water and a mixture of ingredients used to make beer, and where customers can serve their own beer from the tap at the Good Beer Spa in Brussels, Belgium May 12, 2021. REUTERS/Yves Herman

Belgian yoga teacher Dorien Dierckx, 29 from Brussels enjoys a beer while relaxing in a jacuzzi full of hot water and a mixture of ingredients used to make beer, and where customers can serve their own beer from the tap at the Good Beer Spa in Brussels, Belgium May 12, 2021. REUTERS/Yves Herman

French snail grower and soap maker Damien Desrocher mixes ingredients to make snail slime soap in Wahagnies, near Lille, France, May 11, 2021. Picture taken May 11, 2021. REUTERS/Ardee Napolitano

A bottle of snail slime is seen on a lab counter as French snail grower and soap maker Damien Desrocher mixes ingredients to make snail slime soap in Wahagnies, near Lille, France, May 11, 2021. Picture taken May 11, 2021. REUTERS/Ardee Napolitano

Fatema Zuhayli and her daughter Ayah Kutmah prepare ingredients to make sweets the day before Eid at their home in Louisville, Kentucky, U.S. May 11, 2021. REUTERS/Amira Karaoud

Fatema Zuhayli and her daughter Ayah Kutmah prepare ingredients to make sweets the day before Eid at their home in Louisville, Kentucky, U.S. May 11, 2021. REUTERS/Amira Karaoud

Hellen Nanez, who lost 13 relatives to the coronavirus disease (COVID-19) and whose father is being treated for COVID-19 in the Intensive Care Unit, looks at her daughter Luciana after dropping her off at a relative's home so she can buy her father's medicine and shop ingredients to make handmade soap, in Pisco, Peru, May 8, 2021. Picture taken May 8, 2021. REUTERS/Alessandro Cinque

Hellen Nanez, who lost 13 relatives to the coronavirus disease (COVID-19) and whose father is being treated for COVID-19 in the Intensive Care Unit, shops ingredients to make handmade soap for sale, in Pisco, Peru, May 8, 2021. Picture taken May 8, 2021. REUTERS/Alessandro Cinque

Allie Chernick mixes ingredients in an industrial stand mixer for her banana bread in New York, New York, U.S., March 29, 2021. Picture taken March 29, 2021. REUTERS/Roselle Chen

Ahmed Hergal, founder of Italian restaurant L'antica Pizzeria DaPietro, adds ingredients to his 999 DT (360 USD) pizza, covered with luxury foods and edible gold leaf, in Tunis, Tunisia, March 6, 2021. Picture taken March 6, 2021. REUTERS/Jihed Abidellaoui

Ahmed Hergal, founder of Italian restaurant L'antica Pizzeria DaPietro, adds ingredients to his 999 DT (360 USD) pizza, covered with luxury foods and edible gold leaf, in Tunis, Tunisia, March 6, 2021. Picture taken March 6, 2021. REUTERS/Jihed Abidellaoui

Ahmed Hergal, founder of Italian restaurant L'antica Pizzeria DaPietro, adds ingredients to his 999 DT (360 USD) pizza, covered with luxury foods and edible gold leaf, in Tunis, Tunisia, March 6, 2021. Picture taken March 6, 2021. REUTERS/Jihed Abidellaoui

Plant-based meatballs produced by Zhenmeat are seen at the counter as customers choose the ingredients for their meal at a Hope Tree restaurant in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Customers choose the ingredients for their meal at a Hope Tree restaurant which is offering plant-based meatballs produced by Zhenmeat in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Customers choose the ingredients for their meal at a Hope Tree restaurant which is offering plant-based meatballs produced by Zhenmeat in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Plant-based meatballs produced by Zhenmeat are seen at the counter as customers choose the ingredients for their meal at a Hope Tree restaurant in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Sacks of feed ingredients are seen inside a feed plant of the New Hope Liuhe in Xichang, during a government-organised media tour in Liangshan Yi Autonomous Prefecture, Sichuan province, China September 11, 2020. Picture taken September 11, 2020. REUTERS/Tingshu Wang

Salma Zu'bi, founder of the Atan soap brand, mixes the ingredients, which include donkey's milk, used to make her soap, at Salma's lab in Amman, Jordan August 30, 2020. Picture taken August 30, 2020. REUTERS/Muhammad Hamed

Imad, son of the founder of the Atan soap brand Salma Zu'bi, mixes the ingredients, which include donkey's milk, used to make their soap, at Salma's lab in Amman, Jordan August 30, 2020. Picture taken August 30, 2020. REUTERS/Muhammad Hamed

Salma Zu'bi, founder of the Atan soap brand, and her son Imad mix ingredients used to make their soap, at Salma's lab in Amman, Jordan August 30, 2020. Picture taken August 30, 2020. REUTERS/Muhammad Hamed

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

Bruno Le Maire, French Minister of the Economy, Finance, and Recovery, wearing a protective face mask, talks to employees as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, talks with employees as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron and Bruno Le Maire, French Minister of the Economy, Finance, and Recovery, wearing protective face masks, talk to employees as they visit a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron and Bruno Le Maire, French Minister of the Economy, Finance, and Recovery, wearing protective face masks, talk to employees as they visit a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, talks with employees as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool